These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 12934055)

  • 1. The incidence and management of priapism in Western Australia: a 16 year audit.
    Earle CM; Stuckey BG; Ching HL; Wisniewski ZS
    Int J Impot Res; 2003 Aug; 15(4):272-6. PubMed ID: 12934055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracorporeal phenylephrine in the treatment of priapism.
    Muruve N; Hosking DH
    J Urol; 1996 Jan; 155(1):141-3. PubMed ID: 7490814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracavernous injections for erectile dysfunction in patients with cardiovascular diseases and failure or contraindications for sildenafil citrate.
    Israilov S; Niv E; Livne PM; Shmueli J; Engelstein D; Segenreich E; Baniel J
    Int J Impot Res; 2002 Feb; 14(1):38-43. PubMed ID: 11896476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metaraminol--an antidote in corpus cavernosum autoinjection therapy-induced prolonged erection].
    Stief CG; Gilbert P; Wetterhauer U; Bähren W; Thon W; Altwein JE
    Urologe A; 1986 May; 25(3):164-5. PubMed ID: 2426857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Priapism following intracavernous injection of vasoactive substances as a urologic emergency].
    Papadopoulos I; Weichert-Jacobsen K; Wand H
    Z Urol Nephrol; 1990 May; 83(5):233-7. PubMed ID: 2392883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current role of intracavernous therapy in the treatment of erectile dysfunction].
    Asuar Aydillo S
    Arch Esp Urol; 2002 Jun; 55(5):475-82. PubMed ID: 12174413
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prostaglandin E1 injection in erectile dysfunction. Current diagnostic and therapeutic possibilities].
    Schrey A
    Fortschr Med; 1990 Oct; 108(30):577-80. PubMed ID: 2245960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction.
    Meinhardt W; de la Fuente RB; Lycklama à Nijeholt AA; Vermeij P; Zwartendijk J
    Int J Impot Res; 1996 Mar; 8(1):5-7. PubMed ID: 8735187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracavernous self-injection pharmacotherapy program: analysis of results and complications.
    Valdevenito R; Melman A
    Int J Impot Res; 1994 Jun; 6(2):81-91. PubMed ID: 7951702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective randomized study to optimize the dosage of trimix ingredients and compare its efficacy and safety with prostaglandin E1.
    Seyam R; Mohamed K; Akhras AA; Rashwan H
    Int J Impot Res; 2005; 17(4):346-53. PubMed ID: 15772683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of satisfactory rigidity after intracavernosal injection with prostaglandin E1 in men with erectile failure.
    Purvis K; Brekke I; Christiansen E
    Int J Impot Res; 1996 Mar; 8(1):9-16. PubMed ID: 8735188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Priapism induced by intracavernous injection].
    Morales Concepción JC
    Arch Esp Urol; 1992 Oct; 45(8):793-5. PubMed ID: 1466580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral midodrine for prostaglandin e1 induced priapism in spinal cord injured patients.
    Soler JM; Previnaire JG; Mieusset R; Plante P
    J Urol; 2009 Sep; 182(3):1096-100. PubMed ID: 19616810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug-induced priapism--a report of experiences in 101 cases].
    Porst H; van Ahlen H
    Urologe A; 1989 Mar; 28(2):84-7. PubMed ID: 2718298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Priapism associated with concurrent use of phosphodiesterase inhibitor drugs and intracavernous injection therapy.
    McMahon CG
    Int J Impot Res; 2003 Oct; 15(5):383-4. PubMed ID: 14562142
    [No Abstract]   [Full Text] [Related]  

  • 16. Chart for preparation of dilutions of alpha-adrenergic agonists for intracavernous use in treatment of priapism.
    Lee M; Cannon B; Sharifi R
    J Urol; 1995 Apr; 153(4):1182-3. PubMed ID: 7869493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Injection therapy for impotence.
    Kursh ED; Bodner DR; Resnick MI; Althof SE; Turner L; Risen C; Levine SB
    Urol Clin North Am; 1988 Nov; 15(4):625-9. PubMed ID: 3055615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of papaverine plus phentolamine versus prostaglandin E1 in erectile dysfunction.
    Bechara A; Casabé A; Chéliz G; Romano S; Rey H; Fredotovich N
    J Urol; 1997 Jun; 157(6):2132-4. PubMed ID: 9146599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E1 versus mixture of prostaglandin E1, papaverine and phentolamine in nonresponders to high papaverine plus phentolamine doses.
    Bechara A; Casabé A; Chéliz G; Romano S; Fredotovich N
    J Urol; 1996 Mar; 155(3):913-4. PubMed ID: 8583605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What nonresponse to intracavernous injection really indicates: a determination by quantitative analysis.
    Elhanbly S; Schoor R; Elmogy M; Ross L; Hegazy A; Niederberger C
    J Urol; 2002 Jan; 167(1):192-6. PubMed ID: 11743303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.